In this episode of AbbottTalks, hosts Tom Salemi and Kayleen Brown sit down with Dr. Finn Gustafsson, Chief Medical Officer for Abbott’s Heart Failure business, to discuss how Abbott’s technologies are transforming care across every stage of heart failure.

Dr. Gustafsson—who spent decades in academic medicine before joining Abbott—explains how the company’s CentriMag™ System, HeartMate 3™ LVAD, and CardioMEMS™ HF System stabilize, sustain, and empower patients in each phase of the condition. The conversation explores what sets Abbott’s approach apart: early intervention through pulmonary artery pressure monitoring, mechanical circulatory support for critically ill patients, and long-term LVAD therapy that’s helping extend lives beyond five years. Lastly, Dr. Gustafsson shares insights from pivotal studies such as MOMENTUM 3, ARIES, and ASPIRE, which demonstrate how Abbott’s focus on evidence and patient experience is advancing the entire field.

This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/

Thank you for listening to the AbbottTalks podcast!

***

Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

• (00:00:00) - Exploring Abbott's Heart Failure Business and Digital Healthcare Innovation
• (00:03:36) - Transforming OEMs with Connectivity and Predictive Maintenance
• (00:05:54) - Dr. Finn Gustafsson's Journey from Academia to Abbott Heart Failure
• (00:11:20) - Understanding Heart Failure and Abbott's Heart Failure Portfolio
• (00:18:03) - Heart Monitoring Devices Enhance Patient Care and Empowerment
• (00:25:41) - AI-Driven Healthcare Innovation and Regulatory Navigation
• (00:29:20) - Advancements and Patient Impact of HeartMate 3 in Heart Failure
• (00:41:19) - Reducing Bleeding Risks in HeartMate 3 Patients Without Aspirin
• (00:42:45) - Advancements and Future Directions in LVAD Technology and Treatment
• (00:45:16) - Exploring MedTech Innovations and Patient Choices in Heart Devices

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Santosh Prabhu, PhD, Divisional Vice President of Product Development for Abbott’s Structural Heart business, to discuss the company’s expanding portfolio and its impact on patients.

Prabhu outlines Abbott’s transcatheter solutions, including MitraClip, TriClip, and Navitor, and shares updates on next-generation mitral and tricuspid valve replacement programs. He highlights how imaging advancements, new materials, and design innovations are enabling minimally invasive therapies for patients who are not candidates for surgery. The conversation also touches on Abbott’s HeartMates program, which connects and supports patients and families as they navigate cardiovascular conditions.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to AbbottTalks!

***

Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/. Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the cath lab and beyond. Dr. Korngold, an interventional cardiologist turned MedTech leader, discusses the evolution of Abbott’s vascular portfolio and how the company is integrating AI through platforms like Ultreon 2.0 to improve outcomes and procedural efficiency.

The conversation covers specific applications of AI in intravascular imaging, vessel sizing, calcium detection, and future steps in stent placement guidance. He also addresses physician and hospital system perceptions of AI, why he sees it as a GPS-like tool for guiding physicians through complex procedures, and how it may soon impact pre- and post-procedural care.

This episode is brought to you by Resonetics. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8

Want to understand the history of nitinol? Make sure to check out Eric's Veit's Nitinol Innovation: Decade-by-Decade breakdown on LinkedIn: https://www.linkedin.com/posts/eric-veit_nitinol-innovation-decade-by-decade-resonetics-activity-7358601495631552512-hm9D?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAB4aLUBXtw-TjMHSa4dOuAiKreGeEZCZM4

***

Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

• (00:00:00) - Intro + Ethan Korngold's MedTech background
• (00:05:14) - Abbott's Vascular Innovations and AI Integration in Healthcare
• (00:08:54) - Innovations in Nitinol for Medical Device Manufacturing
• (00:12:44) - AI Revolutionizes Vascular Procedures with Enhanced Decision-Making
• (00:19:47) - The Future of Nitinol in Medical and Technological Applications
• (00:24:04) - AI's Role in Enhancing Medical Procedures and Patient Outcomes
• (00:27:14) - Life-Saving Coronary Interventions and Advanced Imaging Techniques
• (00:29:24) - AI Revolutionizing Cath Lab Procedures and Patient Care